Mediworld MAY-JUNE 2020-Final Draft

More documents

Recommendations

Info

Cover Storyability to maintain continuous, direct contact betweenthe cooling cap and scalp for a consistent treatmenttemperature is a key factor in the effectiveness ofDigniCap.There are 2 models of The DigniCap Scalp CoolingSystem, the NEW DigniCap Delta and DigniCap C3. Bothsystems provide effective scalp cooling, but the machine,caps and business models are different.Who is DigniCap scalp cooling for?Cancer patients undergoing chemotherapy for solidtumors, upon recommendation of physician. TheDigniCap Scalp Cooling System is used during each cycleof chemotherapy administration. Scalp cooling shouldbegin with the rst infusion of any chemotherapy thatcauses hair loss.Most patients tolerate scalp cooling with The DigniCapScalp Cooling System very well. Common side effectsinclude a feeling of coldness, headache, scalp painand/or light-headedness. Your doctor can provide a painreliever if you develop a headache. A warm drink andblanket can also help during treatments.Scalp cooling is a proven approach to reducechemotherapy-induced alopecia that hasbeen used successfully by thousands ofpatients worldwide with a variety of cancersand chemotherapy regimens. Dignitana´smulti-site scalp cooling study proved thatscalp cooling is a safe and effective methodfor reducing the risk of chemotherapyinducedhair loss in women with breastcancer. However, almost everyone canexpect to experience some degree of hairloss during chemotherapy.Outcomes are dependent on several factors includingthe chemotherapy regimen, dose, duration of druginfusion, chemotherapy drug metabolism andconcomitant comorbidities.
Cover Storyyou complete your chemotherapy regimen may helpreduce the amount of shedding and maintain your hairquality.How does D ignicap offer patients tomaintain privacy and self-esteem throughoutchemo?Keeping your hair helps many cancer patients feel thatthey have a sense of control over their cancer. For many,hair is a big part of their identity, so they feel that beingable to keep their hair, helps them feel more likethemselves—and helps them not LOOK sick, which isimportant to some mothers with small children and alsoto some people who are still going to work during theirtreatments—they feel more con dent, some say, at work.How does DigniCap encourage a positiveattitude towards the treatment?DigniCap offers the chance to minimize chemotherapyinduced hair loss for men and women with solid tumorundergoing chemotherapy. Most patients who useDigniCap will see a signi cant reduction in the amount ofhair loss from chemotherapy. However, shedding shouldbe expected and is normal for patients using scalpcooling. The amount of shedding experienced will varyfrom patient to patient.Chemotherapy may cause scalp irritation, make the hairdry, brittle, and more difficult to manage. Handling yourhair gently during treatment and for several months afterDescribe its technological advancements?DigniCap is the only scalp cooling system with patenteddual sensors in the cooling compartments for consistentcooling and temperature management, plus a built-insafety sensor to ensure scalp temperature always staysabove 32°F / 0°C. Patients in a multi-center study lled outan Alopecia Self-Report questionnaire. Results clearlyshowed that 101 patients who had an average of3.6cycles of chemotherapy and used TheDigniCap ScalpCooling System were satis ed with the decision to usescalp cooling and expressed higher satisfaction with theirhair quantity as compared to controls. In contrast, the 16patients in the control grop had an average of 1.5 cyclesbefore discontinuing reporting due to hair loss.Women with breast cancer receiving scalp cooling usingDigniCap versus the control in a multi-center clinical trialanswered a Patient Satisfaction with Scalp Coolingsurvey were:Ÿ Signi cantly less likely to lose ≥ 50% of their hairŸ Felt signi cantly more physically attractiveŸ S i g n i c a n t l y l e s s d i s s a t i s e d w i t h t h e i rappearance when dressedŸ Regarded importance of hair signi cantly moreIn your opinion why does hair loss occur duringchemo and how does Dignicap help?Alopecia is a common side effect of the cytostatic drugsgiven during chemotherapy. Cytostatics work by activelytargeting rapidly dividing cells, and hair follicles are someof the fastest growing cells in the body. Becausechemotherapy cannot distinguish between normalrapidly dividing cells and cancerous cells, the hair folliclesare often affected.Chemotherapy affects cells that are in the phase ofdivision or growth. All the cells in the body may beaffected by chemotherapy, not just the cancer cells. Thismeans that even healthy cells, especially cells with a highgrowth rate, such as your hair, are likely to be affected bythe chemotherapy.In your opinion is chemo the only processwhere hair loss occurs? Are there other wayswere hair loss also takes place? Can Dignicapsolve those as well?DigniCap clearance is for use during chemotherapy whena drug is introduced into the system over a short period oftime. The mechanism of the cooling for hair preservationwould therefore not apply to other forms of alopecia
Page 1: Vol. 04, Issue 03, No. 21, May-June
Page 4: CONTENTSEditoria lCover StoryFeatur
Page 7: Cover Storyhemotherapy is a commonC
Page 11 and 12: FeatureNissan ElimelechCEO, Founder
Page 13 and 14: Featuresurgeons the best data avail
Page 15 and 16: FeatureThe nuclear medicine market
Page 17 and 18: 17
Page 19 and 20: Health DestinationIceland has a uni
Page 21 and 22: Health DestinationIceland is divide
Page 23 and 24: News & UpdateCleveland Clinic Abu D
Page 25 and 26: News & UpdateEtihad develops3D-prin
Page 27 and 28: Research30-minute urine test to mea
Page 29 and 30: Product LaunchSkintified:Skincare t

Mediworld MAY-JUNE 2020-Final Draft

Create successful ePaper yourself

Delete template?

Save as template?